1031927-91-9

Basic information

• Product Name: 3(2H)-Isoquinolinone, 6-bromo-
• Synonyms: 3(2H)-Isoquinolinone, 6-bromo-;6-BROMO-2H-ISOQUINOLIN-3-ONE;6-BROMO-3-HYDROXYISOQUINOLINE;6-Bromoisoquinolin-3-ol, 6-Bromoisoquinolin-3(2H)-one;6-broMoisoquinolin-3(2H)-one;6-BroMo-iso-3-hydroxy-quinoline;6-Bromo-3(2H)-isoquinolinone
• CAS NO: 1031927-91-9
• Molecular Formula: C9H6BrNO
• Molecular Weight: 224
• Product Categories: API intermediates
• Mol File: 1031927-91-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 462.4 °C at 760 mmHg
• Flash Point: 233.5 °C
• Appearance: /
• Density: 1.7 g/cm³
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 10.51±0.40(Predicted)
• CAS DataBase Reference: 3(2H)-Isoquinolinone, 6-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: 3(2H)-Isoquinolinone, 6-bromo-(1031927-91-9)
• EPA Substance Registry System: 3(2H)-Isoquinolinone, 6-bromo-(1031927-91-9)

Safety Data

• Hazardous Substances Data: 1031927-91-9(Hazardous Substances Data)

Usage

General Description

3(2H)-Isoquinolinone, 6-bromo- is a chemical compound with the molecular formula C9H6BrNO. It is a derivative of isoquinolinone, which is a heterocyclic compound. The presence of a bromine atom at the 6th position in the isoquinolinone ring imparts unique properties to this compound, making it useful in various research and industrial applications. It has been studied for its potential as an anti-cancer agent, and as a building block for the synthesis of other organic compounds. Additionally, it has been investigated for its potential use in the development of pharmaceuticals and agrochemicals. The unique structure and properties of 3(2H)-Isoquinolinone, 6-bromo- make it a valuable compound for further studies in the fields of medicinal chemistry, organic synthesis, and material science.

Relevant articles and documents

2-AMINOPYRIDINE KINASE INHIBITORS

2-Aminopyridine compounds having the structure of Formula I, and pharmaceutically acceptable salts of these compounds. Compounds of Formula I inhibit the activity of tyrosine kinase enzymes in animals, including humans, and are useful in the treatment and